Si-Man Huang

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Topics

Acute Lymphoblastic Leukemia

Tyrosine Kinase

Clinical Practice

Top Venues

Clinical case reports

OncoTargets and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Si-Man Huang, Tao Tao, Chao-Ling Wan, Tian-Mei Wu, Han-Yu Cao, Yan Qiu, Xiang-Dong Shen, Bin-Ru Wang, Shuai-Shuai Ge, Yan-Yan Li, Tong-Tong Zhang, Bing Wu, Sheng-Li Xue
Flumatinib plus venetoclax as an effective therapy for Philadelphia chromosome-positive acute myeloid leukemia: A case report. Clinical case reports 11 (1) (2023)
Si-Man Huang, Chao-Ling Wan, Han-Yu Cao, Yan-Yan Li, Chong-Sheng Qian, Hai-Xia Zhou, Ming-Zhu Xu, Xiao-Hui Hu, Lan Dai, Hai-Ping Dai, Sheng-Li Xue
Preemptive inotuzumab ozogamicin eradicated measurable residual disease in Ph-negative acute lymphoblastic leukemia relapsed post CD19 CART therapy. Clinical case reports 11 (12) (2023)
Si-Man Huang, Tao Tao, Chao-Ling Wan, Tian-Mei Wu, Han-Yu Cao, Yan Qiu, Xiang-Dong Shen, Bin-Ru Wang, Shuai-Shuai Ge, Yan-Yan Li, Tong-Tong Zhang, Bing Wu, Sheng-Li Xue
Flumatinib plus venetoclax as an effective therapy for Philadelphia chromosome-positive acute myeloid leukemia: A case report. Clinical case reports 11 (1) (2023)
Lei-Si Zhang, Jun Wang, Ming-Zhu Xu, Tian-Mei Wu, Si-Man Huang, Han-Yu Cao, Ai-Ning Sun, Song-Bai Liu, Sheng-Li Xue
Rapid and Efficient Response to Gilteritinib and Venetoclax-Based Therapy in Two AML Patients with FLT3-ITD Mutation Unresponsive to Venetoclax Plus Azacitidine. OncoTargets and therapy 15 (2022)